Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter
Crossref DOI link: https://doi.org/10.1038/nrd4433
Published Online: 2015-04-07
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wallace, John L.
Wang, Rui
Text and Data Mining valid from 2015-04-07
Article History
First Online: 7 April 2015
Competing interests
: J.L.W. is a founder and director of Antibe Therapeutics Inc. R.W. declares no competing interests.